Karin Dott

2.3k citations

24 papers · 2.0k indexed · 2 hit papers · h-index 17

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment

Papers in ⓘ

Virology 9
- HIV Research and Treatment 7
Hematology 5
- Hemophilia Treatment and Research 5
- Blood Coagulation and Thrombosis Mechanisms 3

Co-authors: Yves Rivière (3 shared papers)Jean‐Pierre Lecocq (7 shared papers)Luc Montagnier (4 shared papers)Marc Girard (4 shared papers)Andréa Pavirani (6 shared papers)Marie Paule Kiény (9 shared papers)Pascal Barbry (2 shared papers)Wilfried Dalemans (2 shared papers)
Journals: Protein Engineering Design and Selection (4 papers)Nature (3 papers)Nature Biotechnology (2 papers)Virology (2 papers)FEBS Letters (1 paper)
Partner nations: France United Kingdom United States

In The Last Decade

Karin Dott

24 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation 1991 · 579 citations

Peers

Countries citing papers authored by Karin Dott

Since Specialization

Citations

This map shows the geographic impact of Karin Dott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Dott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Dott more than expected).

Fields of papers citing papers by Karin Dott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Dott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Dott. The network helps show where Karin Dott may publish in the future.

Co-authors

The 25 scholars most cited alongside Karin Dott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karin Dott Line = papers co-authored together Karin Dott links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation Nature ·Wilfried Dalemans, Pascal Barbry, Guy Champigny, Sophie Jallat, Karin Dott, Dominique Dreyer, Ronald G. Crystal, Andréa Pavirani, Jean‐Pierre Lecocq, Michel Lazdunski Hit paper breakdown →	1991	579
2	HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product Nature ·Bruno Guy, Marie Paule Kieny, Yves Rivière, Christian Le Peuch, Karin Dott, Marc Girard, Luc Montagnier, Jean-Pierre Lecocq Hit paper breakdown →	1987	437
3	Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7α-hydroxy dehydroepiandrosterone and 7α-hydroxy pregnenolone Proceedings of the National Academy of Sciences ·Ken A. Rose, Genevieve Stapleton, Karin Dott, Marie Paule Kiény, Ruth Best, Margrit Schwarz, David W. Russell, Ingemar Björkhem, Jonathan R. Seckl, Richard Lathe	1997	184
4	Improved antigenicity of the HIV env protein by cleavage site removal Protein Engineering Design and Selection ·M.P. Kleny, Richard Lathe, Yves Rivière, Karin Dott, D Schmitt, Marc Girard, Luc Montagnier, J. P. Lecocq	1988	103
5	Mutational analysis of the HIV nef protein Virology ·B. Guy, Yves Rivière, Karin Dott, Armelle Régnault, Marie Paule Kiény	1990	97
6	AIDS virus env Protein Expressed from a Recombinant Vaccinia Virus Nature Biotechnology ·M. P. Kieny, G Rautmann, D Schmitt, Karin Dott, Simon Wain–Hobson, Marc Alizon, Marc Girard, S. Chamaret, A G Laurent, Luc Montagnier, Jean‐Pierre Lecocq	1986	88
7	Neurosteroid Hydroxylase CYP7B Journal of Biological Chemistry ·Ken A. Rose, Adrian K. Allan, Stephan D. Gauldie, Genevieve Stapleton, Lorraine Dobbie, Karin Dott, Cécile Martin, Ling Wang, Eva Hedlund, Jonathan R. Seckl, Jan-Ακε Gustafsson, Richard Lathe	2001	72
8	Active γ-carboxylated human factor IX expressed using recombinant DNA techniques Nature ·Henri de la Salle, Werner Altenburger, R. Elkaïm, Karin Dott, A Dieterlé, Robert Drillien, Jean‐Pierre Cazenave, Paul Tolstoshev, Jean‐Pierre Lecocq	1985	70
9	A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein Journal of Virology ·B. Guy, Michel Geist, Karin Dott, Danièle Spehner, Marie Paule Kiény, J. P. Lecocq	1991	70
10	A new recombinant procoagulant protein derived from the cDNA encoding human factor VIII Protein Engineering Design and Selection ·Pierre Meulien, T. Faure, Fabienne Mischler, Huguette Harrer, Pascale Ulrich, Brigitte Bouderbala, Karin Dott, Martine Sainte Marie, Claudine Mazurier, (unknown), H. van de Pol, Jean‐Pierre Cazenave, Mkhael Courtney, Andréa Pavirani	1988	43
11	Improved antlgenldty of the HIV env protein by deavage site removal Protein Engineering Design and Selection ·Marie Paule Kiény, Richard Lathe, Y. Rlvlère, Karin Dott, D. Schmitt, Mélanie Girard, L. Montagnler, J. P. Lecocq	1988	39
12	A change in gating mode leading to increased intrinsic Cl- channel activity compensates for defective processing in a cystic fibrosis mutant corresponding to a mild form of the disease. The EMBO Journal ·Guy Champigny, Jean‐Luc Imler, Édith Puchelle, Wilfried Dalemans, Valentin K. Gribkoff, J. Hinnrasky, Karin Dott, Pascal Barbry, Andréa Pavirani, Michel Lazdunski	1995	33
13	HIV-1 Core Proteins Expressed from Recombinant Vaccinia Viruses AIDS Research and Human Retroviruses ·G Rautmann, Marie Paule Kiény, Renée Brandely, Karin Dott, Marc Girard, Luc Montagnier, Jean‐Pierre Lecocq	1989	23
14	Immunogenicity of HILDA/LIF either in a Soluble or in a Membrane Anchored Form expressed In Vivo by Recombinant Vaccinia Viruses Scandinavian Journal of Immunology ·Jean‐Luc Taupin, Bruce Acres, Karin Dott, D Schmitt, Marie Paule Kiény, N. Gualde, J.‐F‐. MOREAU	1993	17
15	Processing and Characterization of Recombinant von Willebrand Factor Expressed in Different Cell Types Using a Vaccinia Virus Vector Thrombosis and Haemostasis ·Pierre Meulien, Masami Nishino, Claudine Mazurier, Karin Dott, Geneviève Piétu, Sylvie Jorieux, Andréa Pavirani, JP Girma, D Oufkir, Michael Courtney, Dominique Meyer	1992	17
16	Enveloped Virus Is the Major Virus Form Produced during Productive Infection with the Modified Vaccinia Virus Ankara Strain Virology ·Danièle Spehner, Robert Drillien, Fabienne Proamer, Catherine Houssais-Pêcheur, Maria-Antonietta Zanta, Michel Geist, Karin Dott, Jean-Marc Balloul	2000	16
17	Choosing a Host Cell for Active Recombinant Factor VIII Production Using Vaccinia Virus Nature Biotechnology ·Andréa Pavirani, Pierre Meulien, Huguette Harrer, Fabienne Schamber, Karin Dott, Dominique Villeval, Yves Cordier, (unknown), Claudine Mazurier, H. van de Pol, Y. Piquet, Jean‐Pierre Cazenave, Jean‐Pierre Lecocq	1987	16
18	Vaccinia recombinants expressing secreted and transmembrane forms of breast cancer-associated epithelial tumour antigen (ETA) Vaccine ·Mara Hareuveni, Daniel H. Wreschner, Marie Paule Kiény, Karin Dott, Claudie Gautier, Catherine Tomasetto, Iafa Keydar, Pierre Chambon, Richard Lathe	1991	16
19	Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancer. PubMed ·Jean‐Marc Balloul, R B Acres, Michel Geist, Karin Dott, Lenita M. Stefani, D Schmitt, Robert Drillien, Danièle Spehner, Ian F. C. McKenzie, Pei‐Xiang Xing	1994	16
20	Two independent domains of Factor VIII co-expressed using recombinant vaccinia viruses have procoagulant activity Biochemical and Biophysical Research Communications ·Andréa Pavirani, Pierre Meulien, Huguette Harrer, Karin Dott, Fabienne Mischler, (unknown), Claudine Mazurier, Jean‐Pierre Cazenave, Jean‐Pierre Lecocq	1987	10

About Karin Dott

Karin Dott is a scholar working on Virology, Hematology, Genetics, Pharmacology and Infectious Diseases, having authored 24 papers that have together received 2.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), HIV Research and Treatment (7 papers), Hemophilia Treatment and Research (5 papers), Herpesvirus Infections and Treatments (4 papers), Hormonal Regulation and Hypertension (3 papers), Immunotherapy and Immune Responses (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Virology (773 citations), Infectious Diseases (382 citations), Immunology (380 citations), Pulmonary and Respiratory Medicine (548 citations) and Behavioral Neuroscience (43 citations). Karin Dott has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Yves Rivière, Jean‐Pierre Lecocq, Luc Montagnier, Marc Girard, Andréa Pavirani, Marie Paule Kiény, Pascal Barbry, Wilfried Dalemans, Michel Lazdunski and Guy Champigny. Their work appears in journals such as Protein Engineering Design and Selection, Nature, Nature Biotechnology, Virology and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact